BioPharmetics

Bio-Pharmetics is a pharmaceutical development division of Vaso-Meditech focused on the creation of advanced topical and transdermal drug delivery systems. The company utilizes its proprietary Vaso-Genic technology platform, which is designed to enhance the skin's permeability to various therapeutic agents, enabling localized treatment and reducing systemic side effects. Its lead clinical program, Vaso-Prostadil, is a topical formulation of alprostadil for the treatment of erectile dysfunction that has reached Phase 3 clinical trials. Additionally, the company is developing topical versions of ibuprofen for pain management and sumatriptan for migraines. Bio-Pharmetics aims to leverage its delivery platform to repurpose existing drugs for more effective and safer administration.